1. Clinical treatment experience of thyroid cancer with heart disease
Jianhong WANG ; Liyun ZHAO ; Yufang LYU ; Yuansheng RAO ; Haiying LIU ; Xiaojuan YAN ; Jugao FANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2019;54(6):445-449
Objective:
To explore the perioperative clinical treatment of thyroid cancer patients with heart disease.
Methods:
A retrospective analysis was conducted on 39 thyroid cancer patients with heart disease admitted to the Department of Otorhinolaryngology Head and Neck Surgery, Beijing Anzhen Hospital,Capital Medical University from April 2014 to February 2018,including 25 males and 14 females, the age ranged from 59 to 75 years,with an average age of 67.3±6.2 years. Perioperative clinical monitoring indicators included cardiac ultrasound left ventricular ejection fraction (LVEF), degree of vascular stenosis revealed by coronary CT, hypersensitive troponin I (TNI), b-type natriuretic peptide (BNP), fibrinogen degradation products,and coagulation indexes. This panel of patients comprised 26 cases with 50% ≤ LVEF<60%,10 cases with 40% ≤ LVEF<50%, 3 cases with 36% ≤ LVEF<40%, 27 cases with 0≤BNP
2. Exploration of feasibility and safety of transoral robotic surgery in pharyngolaryngeal tumors
Jugao FANG ; Lingzhao MENG ; Jianhong WANG ; Xiandao YUAN ; Yuansheng RAO ; Fan YANG ; Yanjun FENG ; Yongxiang WEI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2018;53(7):512-518
Objective:
To investigate the indication, feasibility, and safety of da Vinci robotic surgical system in pharyngolaryngeal tumor resection.
Methods:
Thirty patients were diagnosed with pharyngolaryngeal tumors and treated with a transoral robotic surgery (TORS) in Beijing Anzhen Hospital from June 1, 2016 through November 30, 2017. Inclusion criteria included lesions of the oropharynx (